Summary
This prediction ended on 28.09.10 with a price of €14.78. With a performance of 7.63%, the BUY prediction by melinda for GSK plc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
GSK plc | -4.830% | -4.830% | 1.253% | 5.633% |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
According to melinda what are the pros and cons of GSK plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread GlaxoSmithKline plc diskutieren
Labor
Second Pharmaceutical Unternehmen GlaxoSmithKline in der Welt zeigt eine starke Präsenz in mehr als zwanzig Bereiche / neuro etc.)
(Vom Mitglied beendet)